Unicycive Therapeutics Insider Trades
NASDAQ: UNCYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Unicycive Therapeutics insider activity
No Unicycive Therapeutics insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Aggarwal Gaurav (Director) reporting a transaction in 652,900 shares on Aug 25, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put UNCY's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
UNCY insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 25, 2025 | Aggarwal GauravDirector | Conversion | 652,900 | — | Form 4 |
| Feb 18, 2025 | Aggarwal GauravDirector | Conversion | 1,400,000 | — | Form 4 |
| Oct 9, 2024 | Aggarwal GauravDirector | Conversion | 5,500,000 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4